Rupal C Mehta
Overview
Explore the profile of Rupal C Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Culler K, Zelnick L, Mehta R, de Sosa G, Kansal M, Rao P, et al.
Heart
. 2025 Feb;
PMID: 39915070
Background: Intercellular adhesion molecule-1 (ICAM-1) is a cell-surface protein that facilitates inflammation through leucocyte adhesion. Approximately 35% of Black individuals carry at least one copy of an missense variant (rs5491;...
2.
Tian L, Jaeger B, Scialla J, Budoff M, Mehta R, Jaar B, et al.
Am J Kidney Dis
. 2024 Aug;
85(1):67-77.e1.
PMID: 39154888
Rationale & Objective: Coronary artery calcification (CAC) progresses rapidly in people with chronic kidney disease (CKD) compared with the general population. We studied the association between CAC progression and higher...
3.
Leidner A, Cai X, Zelnick L, Lee J, Bansal N, Pasch A, et al.
Kidney Med
. 2023 Nov;
5(11):100723.
PMID: 37915961
Rationale & Objective: Heart failure (HF) is an important cause of morbidity and mortality among individuals with chronic kidney disease (CKD). A large body of evidence from preclinical and clinical...
4.
Ogunmoroti O, Osibogun O, Zhao D, Mehta R, Ouyang P, Lutsey P, et al.
PLoS One
. 2022 May;
17(5):e0268759.
PMID: 35613118
Elevated levels of testosterone and fibroblast growth factor 23 (FGF-23) are both independently associated with a higher risk of cardiovascular disease (CVD). However, the relationship between sex hormones and FGF-23...
5.
Molsberry R, Rethy L, Wang M, Mehta R, Lloyd-Jones D, Ning H, et al.
Hypertension
. 2021 Nov;
78(6):1742-1749.
PMID: 34757775
[Figure: see text].
6.
Dorans K, He H, Chen J, Dobre M, Go A, Hamm L, et al.
Nephrol Dial Transplant
. 2021 Oct;
36(12):2224-2231.
PMID: 34697628
Background: Patients with chronic kidney disease (CKD) have an increased risk of peripheral arterial disease (PAD). The ankle-brachial index (ABI), a noninvasive measure of PAD, is a predictor of adverse...
7.
Paul S, Wong M, Akhabue E, Mehta R, Kramer H, Isakova T, et al.
J Am Heart Assoc
. 2021 Aug;
10(16):e020196.
PMID: 34387090
Background Higher circulating fibroblast growth factor 23 (FGF23) associates with greater risk of cardiovascular disease (CVD) and mortality in older adults. The association of FGF23 with cardiovascular outcomes in younger...
8.
Mehta R, Cho M, Cai X, Lee J, Chen J, He J, et al.
Kidney Int
. 2021 Aug;
100(6):1292-1302.
PMID: 34339746
Disordered iron and mineral homeostasis are interrelated complications of chronic kidney disease that may influence cardiovascular and kidney outcomes. In a prospective analysis of 3747 participants in the Chronic Renal...
9.
Chen Y, Zelnick L, Huber M, Wang K, Bansal N, Hoofnagle A, et al.
Am J Kidney Dis
. 2021 Jan;
78(2):226-235.e1.
PMID: 33421453
Rationale & Objective: The clearance of protein-bound solutes by the proximal tubules is an innate kidney mechanism for removing putative uremic toxins that could exert cardiovascular toxicity in humans. However,...
10.
Chen Y, Zelnick L, Wang K, Katz R, Hoofnagle A, Becker J, et al.
Nephrol Dial Transplant
. 2020 Dec;
PMID: 33330914
Background: The secretion of organic solutes by the proximal tubules is an essential intrinsic kidney function. The degree to which secretory solute clearance corresponds with the glomerular filtration rate (GFR)...